Capital International Inc
KITE

Capital International Inc’s Kite Pharma, Inc. KITE Stock Holding History

Capital International Inc’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-10,100
Closed -$1.05M – 169
2017
Q2 		$1.05M Sell
10,100
-2,800
-22% -$228K 0.15% 100
2017
Q1 		$1.01M Sell
12,900
-700
-5% -$43.3K 0.12% 111
2016
Q4 		$610K Buy
13,600
+7,100
+109% +$348K 0.08% 126
2016
Q3 		$363K Buy
+6,500
New +$362K 0.04% 118

Other funds holding KITE

CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Inc's KITE Position: Q3 2017 in Review

Capital International Inc sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 10,100 shares — an estimated $1.05M sold.

Capital International Inc first reported a position in KITE in Q3 2016 and held it in 4 quarters. The position peaked at $1.05M in Q2 2017. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

  • Capital International Inc reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • Capital International Inc sold 10,100 Kite Pharma, Inc. shares in Q3 2017, an estimated $1.05M.
  • Capital International Inc first reported a position in Kite Pharma, Inc. in Q3 2016 and held it in 4 quarters.
  • Capital International Inc's Kite Pharma, Inc. position peaked at $1.05M in Q2 2017.
  • 244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Capital International Inc's 13F filing for Q3 2017, filed 14 Nov 2017.